Associated Banc-Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.64M | Sell |
151,296
-7,215
| -5% | -$189K | 0.09% | 136 |
|
|
2026
Q1 | $4.45M | Sell |
158,511
-1,889
| -1% | -$50.3K | 0.12% | 120 |
|
|
2025
Q4 | $3.99M | Sell |
160,400
-4,709
| -3% | -$119K | 0.1% | 128 |
|
|
2025
Q3 | $4.21M | Sell |
165,109
-2,125
| -1% | -$52.4K | 0.11% | 129 |
|
|
2025
Q2 | $4.05M | Sell |
167,234
-28,410
| -15% | -$663K | 0.11% | 130 |
|
|
2025
Q1 | $4.96M | Sell |
195,644
-28,318
| -13% | -$741K | 0.15% | 115 |
|
|
2024
Q4 | $5.94M | Sell |
223,962
-27,951
| -11% | -$758K | 0.18% | 106 |
|
|
2024
Q3 | $7.29M | Sell |
251,913
-33,895
| -12% | -$989K | 0.21% | 104 |
|
|
2024
Q2 | $8M | Buy |
285,808
+5,117
| +2% | +$141K | 0.25% | 88 |
|
|
2024
Q1 | $7.79M | Sell |
280,691
-6,311
| -2% | -$175K | 0.25% | 91 |
|
|
2023
Q4 | $8.26M | Sell |
287,002
-43,749
| -13% | -$1.32M | 0.29% | 88 |
|
|
2023
Q3 | $11M | Buy |
330,751
+2,249
| +0.7% | +$79.5K | 0.42% | 66 |
|
|
2023
Q2 | $12M | Sell |
328,502
-7,510
| -2% | -$292K | 0.46% | 64 |
|
|
2023
Q1 | $13.7M | Buy |
336,012
+2,256
| +0.7% | +$97.4K | 0.55% | 58 |
|
|
2022
Q4 | $17.1M | Sell |
333,756
-1,789
| -0.5% | -$85.8K | 0.71% | 45 |
|
|
2022
Q3 | $14.7M | Buy |
335,545
+7,896
| +2% | +$384K | 0.68% | 47 |
|
|
2022
Q2 | $17.2M | Buy |
327,649
+3,554
| +1% | +$181K | 0.75% | 42 |
|
|
2022
Q1 | $16.8M | Buy |
324,095
+17,130
| +6% | +$889K | 0.65% | 51 |
|
|
2021
Q4 | $18.1M | Buy |
306,965
+3,539
| +1% | +$175K | 0.66% | 49 |
|
|
2021
Q3 | $13.1M | Sell |
303,426
-10,370
| -3% | -$459K | 0.52% | 61 |
|
|
2021
Q2 | $12.3M | Sell |
313,796
-564,318
| -64% | -$21.9M | 0.49% | 63 |
|
|
2021
Q1 | $28.7M | Buy |
878,114
+400,382
| +84% | +$14.2M | 1.78% | 10 |
|
|
2020
Q4 | $17.6M | Sell |
477,732
-44,420
| -9% | -$1.63M | 0.69% | 42 |
|
|
2020
Q3 | $18.2M | Sell |
522,152
-63,420
| -11% | -$2.22M | 0.78% | 42 |
|
|
2020
Q2 | $18.2M | Sell |
585,572
-393,802
| -40% | -$13.4M | 0.82% | 41 |
|
|
2020
Q1 | $30.3M | Buy |
979,374
+107,696
| +12% | +$3.67M | 1.62% | 11 |
|
|
2019
Q4 | $32.4M | Buy |
871,678
+10,644
| +1% | +$379K | 1.61% | 10 |
|
|
2019
Q3 | $29.4M | Buy |
861,034
+230,302
| +37% | +$8.37M | 1.58% | 12 |
|
|
2019
Q2 | $25.9M | Buy |
630,732
+2,949
| +0.5% | +$117K | 1.42% | 16 |
|
|
2019
Q1 | $25.3M | Sell |
627,783
-71,120
| -10% | -$2.85M | 1.46% | 16 |
|
|
2018
Q4 | $28.9M | Sell |
698,903
-173,966
| -20% | -$7.22M | 1.89% | 7 |
|
|
2018
Q3 | $36.5M | Sell |
872,869
-12,298
| -1% | -$473K | 2.02% | 7 |
|
|
2018
Q2 | $30.5M | Sell |
885,167
-46,718
| -5% | -$1.6M | 1.78% | 8 |
|
|
2018
Q1 | $31.4M | Buy |
931,885
+10,312
| +1% | +$355K | 1.78% | 8 |
|
|
2017
Q4 | $31.7M | Sell |
921,573
-16,909
| -2% | -$577K | 1.71% | 8 |
|
|
2017
Q3 | $31.8M | Buy |
938,482
+14,960
| +2% | +$481K | 1.75% | 8 |
|
|
2017
Q2 | $29.4M | Buy |
923,522
+36,921
| +4% | +$1.16M | 1.67% | 8 |
|
|
2017
Q1 | $28.8M | Buy |
886,601
+39,193
| +5% | +$1.24M | 1.71% | 7 |
|
|
2016
Q4 | $26.1M | Buy |
847,408
+40,264
| +5% | +$1.23M | 1.63% | 8 |
|
|
2016
Q3 | $25.9M | Buy |
807,144
+111,400
| +16% | +$3.72M | 1.65% | 9 |
|
|
2016
Q2 | $23.2M | Buy |
695,744
+238,208
| +52% | +$7.6M | 1.49% | 12 |
|
|
2016
Q1 | $12.9M | Sell |
457,536
-18,453
| -4% | -$527K | 0.85% | 32 |
|
|
2015
Q4 | $14.6M | Sell |
475,989
-22,219
| -4% | -$699K | 0.96% | 29 |
|
|
2015
Q3 | $14.8M | Buy |
498,208
+458
| +0.1% | +$14.7K | 1.04% | 26 |
|
|
2015
Q2 | $15.8M | Sell |
497,750
-5,126
| -1% | -$167K | 1.02% | 28 |
|
|
2015
Q1 | $16.6M | Buy |
502,876
+8,831
| +2% | +$281K | 1.05% | 26 |
|
|
2014
Q4 | $14.6M | Sell |
494,045
-4,757
| -1% | -$136K | 0.92% | 30 |
|
|
2014
Q3 | $14M | Sell |
498,802
-44,587
| -8% | -$1.25M | 0.92% | 30 |
|
|
2014
Q2 | $15.3M | Sell |
543,389
-1,880
| -0.3% | -$53.6K | 1% | 27 |
|
|
2014
Q1 | $16.6M | Buy |
545,269
+15,088
| +3% | +$450K | 1.15% | 21 |
|
|
2013
Q4 | $15.4M | Sell |
530,181
-24,839
| -4% | -$723K | 1.11% | 22 |
|
|
2013
Q3 | $15.1M | Sell |
555,020
-35,400
| -6% | -$963K | 1.2% | 19 |
|
|
2013
Q2 | $15.7M | Buy |
+590,420
| New | +$16.3M | 1.29% | 16 |
|
Other funds holding PFE
Associated Banc-Corp's PFE Position: Q2 2026 in Review
Associated Banc-Corp reduced its Pfizer (PFE) stake by 4.6% in Q2 2026, selling an estimated $189K and leaving 151,296 shares worth $3.64M. The position accounts for 0.09% of the portfolio, ranked #136.
Associated Banc-Corp first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $36.5M in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Associated Banc-Corp held 151,296 shares of Pfizer worth $3.64M as of Q2 2026.
- Associated Banc-Corp sold 7,215 Pfizer shares in Q2 2026, an estimated $189K.
- Pfizer made up 0.09% of Associated Banc-Corp's portfolio in Q2 2026, its #136 holding.
- Associated Banc-Corp first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Associated Banc-Corp's Pfizer position peaked at $36.5M in Q3 2018.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Associated Banc-Corp's 13F filing for Q2 2026, filed 31 Jul 2026.